-
Signature
-
/s/ Elizabeth E. Reed, Attorney-in-Fact
-
Issuer symbol
-
TVTX
-
Transactions as of
-
31 Oct 2025
-
Net transactions value
-
-$195,685
-
Form type
-
4
-
Filing time
-
04 Nov 2025, 16:05:11 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Heerma Peter |
CHIEF COMMERCIAL OFFICER |
C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO |
/s/ Elizabeth E. Reed, Attorney-in-Fact |
03 Nov 2025 |
0001789617 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TVTX |
Common Stock |
Sale |
$195,685 |
-5,591 |
-4.5% |
$35.00 |
119,071 |
31 Oct 2025 |
Direct |
F1 |
| transaction |
TVTX |
Common Stock |
Gift |
$0 |
-1,078 |
-0.91% |
$0.000000 |
117,993 |
03 Nov 2025 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: